Literature DB >> 8892926

Postbinding events mediated by human immunodeficiency virus type 1 are sensitive to modifications in the D4-transmembrane linker region of CD4.

S Moir1, J Perreault, L Poulin.   

Abstract

Evidence from both structural and functional studies of the CD4 molecule suggests that several domains, including the transmembrane (TM) domain and the adjoining extracellular region (D4-TM linker), contribute to the post-gp12O-binding events leading to human immunodeficiency virus-mediated membrane fusion. To investigate such a role in syncytium formation and cell-free infectivity, we generated several deletion and substitution mutations in the TM and D4-TM linker regions of the CD4 molecule. We found that while the TM domain of CD4 was dispensable for cell-cell and virus-cell interactions, modifications in the D4-TM linker led to perturbations in both processes. Deletion of the five amino acid residues linking D4 to the TM domain resulted in a delayed and reduced capacity to form syncytia, whereas replacement of the residues with the heterologous sequence from the CD8 molecule restored the kinetic profile to wild-type CD4 levels. On the other hand, both mutants of the CD4 D4-TM linker demonstrated delayed cell-free human immunodeficiency virus type 1 infectivity profiles. The defective fusion capacity may be linked to structural perturbations identified with anti-CD4 monoclonal antibodies in the D1-D2 interface and D3 domain of the deletion mutant yet absent in D1 and D4. While all cells were found to bind comparable levels of gp120, both D4-TM linker mutants appeared to induce a decrease in the V3 loop exposure of bound gp120. This underexposure may explain the delays in cell-free infectivities observed for both of these mutants. Together, these findings confirm a role for regions of the CD4 molecule located outside D1 in post-gp120-binding events and suggest that the D4-TM interface contributes to the conformational changes that direct the fusion process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892926      PMCID: PMC190875     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

1.  Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gp120.

Authors:  J A McKeating; J Cordell; C J Dean; P Balfe
Journal:  Virology       Date:  1992-12       Impact factor: 3.616

2.  Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. Dissecting the basis for its inhibitory effect on HIV-induced cell fusion.

Authors:  L C Burkly; D Olson; R Shapiro; G Winkler; J J Rosa; D W Thomas; C Williams; P Chisholm
Journal:  J Immunol       Date:  1992-09-01       Impact factor: 5.422

3.  Functional epitope analysis of the human CD4 molecule: antibodies that inhibit human immunodeficiency virus type 1 gene expression bind to the immunoglobulin CDR3-like region of CD4.

Authors:  M Benkirane; M Hirn; D Carrière; C Devaux
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

4.  Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules.

Authors:  H Golding; D S Dimitrov; J Manischewitz; C C Broder; J Robinson; S Fabian; D R Littman; C K Lapham
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

5.  Interdomain communication of T-cell CD4 studied by absorbance and fluorescence difference spectroscopy measurements of urea-induced unfolding.

Authors:  S W Tendian; D G Myszka; R W Sweet; I M Chaiken; C G Brouillette
Journal:  Biochemistry       Date:  1995-05-16       Impact factor: 3.162

6.  A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4+ cells.

Authors:  J P Moore; Q J Sattentau; P J Klasse; L C Burkly
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

7.  CD4 changes conformation upon ligand binding.

Authors:  G Szabò; P S Pine; J L Weaver; P E Rao; A Aszalos
Journal:  J Immunol       Date:  1992-12-01       Impact factor: 5.422

8.  Localized conformational changes in the N-terminal domain of CD4 identified in competitive binding assay of monoclonal antibodies and HIV-1 envelope glycoprotein.

Authors:  L Walker; D Wilks; J O'Brien; J Habeshaw; A Dalgleish
Journal:  AIDS Res Hum Retroviruses       Date:  1992-06       Impact factor: 2.205

9.  Cell-to-cell fusion, but not virus entry in macrophages by T-cell line tropic HIV-1 strains: a V3 loop-determined restriction.

Authors:  G Simmons; A McKnight; Y Takeuchi; H Hoshino; P R Clapham
Journal:  Virology       Date:  1995-06-01       Impact factor: 3.616

10.  The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure.

Authors:  U Moebius; L K Clayton; S Abraham; S C Harrison; E L Reinherz
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

View more
  3 in total

1.  A species-specific amino acid difference in the macaque CD4 receptor restricts replication by global circulating HIV-1 variants representing viruses from recent infection.

Authors:  Daryl Humes; Sandra Emery; Elizabeth Laws; Julie Overbaugh
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

2.  Crystal structure of HIV-1 primary receptor CD4 in complex with a potent antiviral antibody.

Authors:  Michael M Freeman; Michael S Seaman; Sophia Rits-Volloch; Xinguo Hong; Chia-Ying Kao; David D Ho; Bing Chen
Journal:  Structure       Date:  2010-12-08       Impact factor: 5.006

3.  Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.

Authors:  P D Kwong; R Wyatt; J Robinson; R W Sweet; J Sodroski; W A Hendrickson
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.